AMID
Argent Mid Cap ETF Argent Mid Cap ETF
AMID is an actively managed ETF that provides exposure to US mid-cap stocks perceived to be undergoing positive change. The fund employs a multi-step selection process based on quantitative and fundamental research.
US
EQUITY
Active
MANAGEMENT STYLE
$ 120.0 M
ASSETS UNDER MGMT
52 bp
EXPENSES
Fund Basics
| Inception date | Aug 17, 2022 |
| Regulation | Open-Ended Fund |
| Fund Website | link... |
| Distributions | Annually |
| Currency | USD |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | No |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
Complete list +
| VICTORY CAPITAL HOLDING - A | 4.9 % |
| MEDPACE HOLDINGS, INC. | 3.7 % |
| UNITED RENTALS INC | 3.2 % |
| OKTA, INC. CLASS A | 2.9 % |
| US FOODS HOLDING CORP. | 2.7 % |
| HINGE HEALTH INC-A | 2.6 % |
| LPL FINANCIAL HOLDINGS INC | 2.5 % |
| CINTAS CORP | 2.5 % |
| AMETEK INC | 2.4 % |
| HILTON WORLDWIDE HOLDINGS, INC. | 2.4 % |
Constituent Breakdown
| Number of holdings | 45 |
| Herfindahl-Hirschman Index | 236 |
| Wgt avg mkt cap (mns) | $25,235 |
| Large cap (>$10bn) | 68.5% |
| Mid cap ($2-10bn) | 26.6% |
| Small cap (<$2bn) | 0.0% |
| Developed mkts. | 97.5% |
| Emerging mkts. | 0.0% |
Sector Breakdown
Country Exposure
 |
UNITED STATES | 87.6 % |
 |
BRITAIN | 2.2 % |
 |
CANADA | 2.1 % |
 |
AUSTRALIA | 1.8 % |
 |
IRELAND | 1.4 % |
Historical Performance
Standardized Performance (as of 09/30/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | 8.3% | 6.8% | 1.4% | 11.8% | -- | -- | -- | 9.7% |
| Dividend Yield | 0.0% | 0.4% | 0.3% | 0.4% | -- | -- | -- | 0.4% |
| Total Returns | 8.3% | 7.2% | 1.7% | 12.3% | -- | -- | -- | 10.1% | Ann. Volatility | 16.9% | 16.4% | 18.2% | 17.8% | -- | -- | -- | 18.8% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 1.02 | 65% |
| MSCI EAFE | 0.74 | 51% |
| MSCI Emg Mkts | 0.45 | 47% |
Liquidity Measures
| Avg. volume (000) | 8 |
| ADV traded (mns) | $0 |
| Turnover | 0.2% |
| Avg. Bid/Ask (% of price) | 0.14% |
Technical Indicators
| 30d moving avg. (EMA) | $36.51 |
| Relative strength (RSI) | 49 |
| MACD/Signal | -0.05/0.02 |
| Bollinger Bands (Upper/Lower) | $37.33/$35.85 |
| Short interest (% of AUM) | 0.1% |
Distributions
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. AMID |
Expenses vs. AMID |
ALTAR Score™ vs. AMID |
|---|---|---|---|---|
| ABIG | Argent Large Cap ETF | 18.9% | -3 bp | -0.1% |
| IVOG | Vanguard S&P Mid-Cap 400 Growth ETF | 17.1% | -42 bp | 0.0% |
| RFG | Invesco S&P Midcap 400 Pure Growth ETF | 15.8% | -17 bp | -0.7% |
| MDYG | State Street SPDR S&P 400 Mid Cap Growth ETF | 15.5% | -37 bp | +0.0% |
| IJK | iShares S&P Mid-Cap 400 Growth ETF | 15.2% | -36 bp | +0.0% |
| MCOW | Pacer S&P MidCap 400 Quality FCF Aristocrats ETF | 14.5% | -3 bp | +0.9% |
| BUL | Pacer US Cash Cows Growth ETF | 14.4% | +8 bp | +0.5% |
| PDP | Invesco Dorsey Wright Momentum ETF | 14.0% | +10 bp | -1.7% |
| QMOM | Alpha Architect U.S. Quantitative Momentum ETF | 12.9% | -24 bp | -1.0% |
| FFTY | Innovator IBD 50 ETF | 12.8% | +51 bp | +0.2% |
Risk and Returns: AMID vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (USD)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 11/5/2026
Peer Group Comparison
Sample data. Subscribe for access.
Historical Valuation Trends Sample data. Subscribe for access.
Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
5.6%
ALTAR SCORE™
52nd
PERCENTILE
NEUTRAL
ETFRC RATING
There are 1,393 funds in the US Equity category with an average
ALTAR Score™ of 5.5% and a standard deviation
of 2.0%. AMID's ALTAR Score™ is approximately 0.1 standard
deviations above the category average. This places AMID in the 52nd percentile
among funds in the category.
Sell-Side Consensus
$42.25
PRICE TARGET
+15.6%
UPSIDE